2926 - 2950 of 6255 Results
Title
Year
-
OPENTitle: Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome AssessmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1319End Page: 1340Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00375-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00375-3.pdfCitation Count: 23
-
OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 7
-
OPENTitle: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein ToxicityJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 1018End Page: 1036Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-022-01199-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-022-01199-7.pdfCitation Count: 14
-
OPENTitle: The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in EnglandJournal Name: PharmacoEconomicsPublisher: Springer Science and Business Media LLCVol: 40Issue #: 5Start Page: 559End Page: 574Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40273-022-01132-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40273-022-01132-y.pdfCitation Count: 10
-
OPENTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 11
-
OPENTitle: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stressJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-022-20261-0Best OA location URL: https://www.nature.com/articles/s41598-022-20261-0.pdfCitation Count: 20
-
OPENTitle: Temporal order of clinical and biomarker changes in familial frontotemporal dementiaJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 10Start Page: 2194End Page: 2206Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01942-9Best OA location URL: https://www.nature.com/articles/s41591-022-01942-9.pdfCitation Count: 98
-
OPENTitle: Deep brain stimulation for obsessive–compulsive disorder: a crisis of accessJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 8Start Page: 1529End Page: 1532Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41591-022-01879-zCitation Count: 62
-
OPENTitle: Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signalsJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 28Issue #: 10Start Page: 2207End Page: 2215Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-022-01932-xBest OA location URL: https://www.nature.com/articles/s41591-022-01932-x.pdfCitation Count: 202
-
OPENTitle: neuromaps: structural and functional interpretation of brain mapsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 11Start Page: 1472End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41592-022-01625-wBest OA location URL: https://www.nature.com/articles/s41592-022-01625-w.pdfCitation Count: 258
-
OPENTitle: Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brainJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 4Start Page: 504End Page: 514Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41593-022-01031-7Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9245608Citation Count: 52
-
OPENTitle: Microglia ferroptosis is regulated by SEC24B and contributes to neurodegenerationJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 1Start Page: 12End Page: 26Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01221-3Best OA location URL: https://www.nature.com/articles/s41593-022-01221-3.pdfCitation Count: 242
-
OPENTitle: Deep Brain Stimulation for Parkinson’s Disease: Why Earlier Use Makes Shared Decision Making ImportantJournal Name: NeuroethicsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12152-022-09496-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s12152-022-09496-w.pdfCitation Count: 3
- Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRI2022OPENTitle: Pitfalls and Recommended Strategies and Metrics for Suppressing Motion Artifacts in Functional MRIJournal Name: NeuroinformaticsPublisher: Springer Science and Business Media LLCVol: 20Issue #: 4Start Page: 879End Page: 896Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12021-022-09565-8Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2021/09/20/2021.09.18.460908.full.pdfCitation Count: 5
-
OPENTitle: Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variablesJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 4803End Page: 4809Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-06061-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-06061-4.pdfCitation Count: 21
-
OPENTitle: Uncovering clinical and radiological asymmetry in progressive supranuclear palsy—Richardson’s syndromeJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 43Issue #: 6Start Page: 3677End Page: 3682Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-022-05919-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-022-05919-x.pdfCitation Count: 5
-
OPENTitle: Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brainsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 28Issue #: 3Start Page: 1272End Page: 1283Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-022-01875-2Best OA location URL: https://doi.org/10.1038/s41380-022-01875-2Citation Count: 42
-
OPENTitle: Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brainJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00509-5Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-021-00509-5Citation Count: 51
-
OPENTitle: Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencingJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 28Issue #: 3Start Page: 1327End Page: 1336Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-022-01926-8Best OA location URL: https://www.nature.com/articles/s41380-022-01926-8.pdfCitation Count: 16
-
OPENTitle: Within-host evolution of a gut pathobiont facilitates liver translocationJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 607Issue #: 7919Start Page: 563End Page: 570Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41586-022-04949-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9308686Citation Count: 121
-
OPENTitle: Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairmentJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 2Issue #: 10Start Page: 923End Page: 940Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s43587-022-00290-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9833817Citation Count: 34
-
OPENTitle: Integrating human brain proteomes with genome-wide association data implicates novel proteins in post-traumatic stress disorderJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 27Issue #: 7Start Page: 3075End Page: 3084Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-022-01544-4Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9233006Citation Count: 25
-
OPENTitle: Shared mechanisms across the major psychiatric and neurodegenerative diseasesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31873-5Best OA location URL: https://escholarship.org/content/qt23t9767x/qt23t9767x.pdfCitation Count: 125
-
OPENTitle: Multimodal deep learning for Alzheimer’s disease dementia assessmentJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-31037-5Best OA location URL: https://www.nature.com/articles/s41467-022-31037-5.pdfCitation Count: 180
-
OPENTitle: Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degenerationJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-022-32944-3Best OA location URL: https://www.nature.com/articles/s41467-022-32944-3.pdfCitation Count: 43